annual SGA:
$0.00-$275.27M(-100.00%)Summary
- As of today (September 17, 2025), FOLD annual SGA is $0.00, with the most recent change of -$275.27 million (-100.00%) on December 31, 2024.
- During the last 3 years, FOLD annual SGA has fallen by -$192.71 million (-100.00%).
- FOLD annual SGA is now -100.00% below its all-time high of $275.27 million, reached on December 31, 2023.
Performance
FOLD SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$91.83M(-100.00%)Summary
- As of today (September 17, 2025), FOLD quarterly SGA is $0.00, with the most recent change of -$91.83 million (-100.00%) on June 30, 2025.
- Over the past year, FOLD quarterly SGA has dropped by -$73.58 million (-100.00%).
- FOLD quarterly SGA is now -100.00% below its all-time high of $91.83 million, reached on March 31, 2025.
Performance
FOLD quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$11.04B-$38.10M(-0.35%)Summary
- As of today (September 17, 2025), FOLD TTM SGA is -$11.04 billion, with the most recent change of -$38.10 million (-0.35%) on June 30, 2025.
- Over the past year, FOLD TTM SGA has dropped by -$11.34 billion (-3812.08%).
- FOLD TTM SGA is now -29488.80% below its all-time high of -$37.32 million.
Performance
FOLD TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
FOLD Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | -3812.1% |
| 3 y3 years | -100.0% | -100.0% | -5231.6% |
| 5 y5 years | -100.0% | -100.0% | -7095.9% |
FOLD Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low | -18.3% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low | -53.1% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low | <-9999.0% | at low |
FOLD Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $166.93M(-30.6%) |
| Mar 2025 | - | $91.83M(>+9900.0%) | $240.51M(+1.6%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $236.71M(-22.9%) |
| Sep 2024 | - | $75.11M(+2.1%) | $306.95M(+3.2%) |
| Jun 2024 | - | $73.58M(-16.4%) | $297.50M(+2.8%) |
| Mar 2024 | - | $88.03M(+25.3%) | $289.34M(+5.1%) |
| Dec 2023 | $275.27M(+29.2%) | $70.24M(+7.0%) | $275.27M(+6.2%) |
| Sep 2023 | - | $65.65M(+0.3%) | $259.31M(+7.6%) |
| Jun 2023 | - | $65.42M(-11.5%) | $240.93M(+5.3%) |
| Mar 2023 | - | $73.96M(+36.3%) | $228.88M(+7.4%) |
| Dec 2022 | $213.04M(+10.6%) | $54.27M(+14.8%) | $213.04M(-1.5%) |
| Sep 2022 | - | $47.27M(-11.4%) | $216.37M(+0.5%) |
| Jun 2022 | - | $53.38M(-8.2%) | $215.20M(+5.4%) |
| Mar 2022 | - | $58.12M(+0.9%) | $204.10M(+5.9%) |
| Dec 2021 | $192.71M(+23.2%) | $57.60M(+24.9%) | $192.71M(+7.8%) |
| Sep 2021 | - | $46.11M(+9.1%) | $178.79M(+4.8%) |
| Jun 2021 | - | $42.28M(-9.5%) | $170.54M(+4.7%) |
| Mar 2021 | - | $46.73M(+7.0%) | $162.92M(+4.2%) |
| Dec 2020 | $156.41M(-7.9%) | $43.69M(+15.4%) | $156.41M(+0.2%) |
| Sep 2020 | - | $37.85M(+9.2%) | $156.02M(-1.2%) |
| Jun 2020 | - | $34.66M(-13.8%) | $157.85M(-4.8%) |
| Mar 2020 | - | $40.22M(-7.1%) | $165.77M(-2.4%) |
| Dec 2019 | $169.86M(+33.5%) | $43.30M(+9.1%) | $169.86M(+2.7%) |
| Sep 2019 | - | $39.68M(-6.8%) | $165.33M(+5.0%) |
| Jun 2019 | - | $42.58M(-3.9%) | $157.51M(+9.3%) |
| Mar 2019 | - | $44.30M(+14.3%) | $144.11M(+13.3%) |
| Dec 2018 | $127.20M(+43.5%) | $38.77M(+21.6%) | $127.20M(+8.7%) |
| Sep 2018 | - | $31.87M(+9.2%) | $117.02M(+9.6%) |
| Jun 2018 | - | $29.17M(+6.5%) | $106.80M(+10.2%) |
| Mar 2018 | - | $27.40M(-4.1%) | $96.94M(+9.3%) |
| Dec 2017 | $88.67M(+24.6%) | $28.58M(+32.0%) | $88.67M(+12.6%) |
| Sep 2017 | - | $21.65M(+12.1%) | $78.77M(+5.6%) |
| Jun 2017 | - | $19.31M(+0.9%) | $74.59M(+0.0%) |
| Mar 2017 | - | $19.13M(+2.4%) | $74.58M(+4.8%) |
| Dec 2016 | $71.15M(+50.5%) | $18.68M(+6.9%) | $71.15M(+2.1%) |
| Sep 2016 | - | $17.47M(-9.5%) | $69.66M(+3.1%) |
| Jun 2016 | - | $19.30M(+22.9%) | $67.56M(+19.5%) |
| Mar 2016 | - | $15.70M(-8.7%) | $56.54M(+19.6%) |
| Dec 2015 | $47.27M(+128.2%) | $17.19M(+11.8%) | $47.27M(+32.8%) |
| Sep 2015 | - | $15.37M(+85.7%) | $35.59M(+39.6%) |
| Jun 2015 | - | $8.28M(+28.8%) | $25.49M(+16.0%) |
| Mar 2015 | - | $6.43M(+16.5%) | $21.97M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $20.72M(+9.7%) | $5.52M(+4.7%) | $20.72M(+4.6%) |
| Sep 2014 | - | $5.27M(+10.9%) | $19.80M(+3.3%) |
| Jun 2014 | - | $4.75M(-8.2%) | $19.17M(-0.4%) |
| Mar 2014 | - | $5.18M(+12.4%) | $19.25M(+1.9%) |
| Dec 2013 | $18.89M(-2.4%) | $4.61M(-0.6%) | $18.89M(+0.8%) |
| Sep 2013 | - | $4.63M(-4.0%) | $18.74M(-1.9%) |
| Jun 2013 | - | $4.83M(+0.1%) | $19.10M(-4.9%) |
| Mar 2013 | - | $4.82M(+8.3%) | $20.09M(+3.8%) |
| Dec 2012 | $19.36M(-2.6%) | $4.46M(-10.8%) | $19.36M(+2.9%) |
| Sep 2012 | - | $5.00M(-14.2%) | $18.83M(+1.1%) |
| Jun 2012 | - | $5.82M(+42.1%) | $18.61M(-4.6%) |
| Mar 2012 | - | $4.09M(+4.5%) | $19.52M(-1.5%) |
| Dec 2011 | $19.88M(+26.9%) | $3.92M(-18.1%) | $19.82M(+0.5%) |
| Sep 2011 | - | $4.78M(-28.8%) | $19.73M(+4.7%) |
| Jun 2011 | - | $6.72M(+52.7%) | $18.84M(+16.7%) |
| Mar 2011 | - | $4.40M(+15.1%) | $16.14M(+3.0%) |
| Dec 2010 | $15.66M(-21.6%) | $3.82M(-1.8%) | $15.66M(-3.2%) |
| Sep 2010 | - | $3.89M(-3.2%) | $16.18M(-7.6%) |
| Jun 2010 | - | $4.02M(+2.4%) | $17.50M(-6.4%) |
| Mar 2010 | - | $3.92M(-9.5%) | $18.70M(-6.4%) |
| Dec 2009 | $19.97M(+1.6%) | $4.34M(-16.8%) | $19.97M(+27.7%) |
| Sep 2009 | - | $5.22M(-0.1%) | $15.63M(+5.7%) |
| Jun 2009 | - | $5.22M(+0.5%) | $14.79M(+0.7%) |
| Mar 2009 | - | $5.20M(>+9900.0%) | $14.68M(+0.1%) |
| Dec 2008 | $19.67M(+28.7%) | $0.00(-100.0%) | $14.68M(-26.5%) |
| Sep 2008 | - | $4.37M(-14.6%) | $19.96M(+2.1%) |
| Jun 2008 | - | $5.12M(-1.3%) | $19.54M(+11.0%) |
| Mar 2008 | - | $5.19M(-1.9%) | $17.61M(+15.3%) |
| Dec 2007 | $15.28M(+24.4%) | $5.28M(+33.6%) | $15.28M(+52.9%) |
| Sep 2007 | - | $3.95M(+24.0%) | $9.99M(+65.5%) |
| Jun 2007 | - | $3.19M(+11.9%) | $6.04M(+111.9%) |
| Mar 2007 | - | $2.85M(>+9900.0%) | $2.85M(>+9900.0%) |
| Dec 2006 | $12.28M(+78.5%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2005 | $6.88M(+230.4%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2005 | - | $0.00 | $0.00 |
| Dec 2004 | $2.08M(+107.0%) | - | - |
| Dec 2003 | $1.01M | - | - |
FAQ
- What is Amicus Therapeutics, Inc. annual SGA?
- What is the all time high annual SGA for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. annual SGA year-on-year change?
- What is Amicus Therapeutics, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. quarterly SGA year-on-year change?
- What is Amicus Therapeutics, Inc. TTM SGA?
- What is the all time high TTM SGA for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. TTM SGA year-on-year change?
What is Amicus Therapeutics, Inc. annual SGA?
The current annual SGA of FOLD is $0.00
What is the all time high annual SGA for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high annual SGA is $275.27M
What is Amicus Therapeutics, Inc. annual SGA year-on-year change?
Over the past year, FOLD annual SGA has changed by -$275.27M (-100.00%)
What is Amicus Therapeutics, Inc. quarterly SGA?
The current quarterly SGA of FOLD is $0.00
What is the all time high quarterly SGA for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high quarterly SGA is $91.83M
What is Amicus Therapeutics, Inc. quarterly SGA year-on-year change?
Over the past year, FOLD quarterly SGA has changed by -$73.58M (-100.00%)
What is Amicus Therapeutics, Inc. TTM SGA?
The current TTM SGA of FOLD is -$11.04B
What is the all time high TTM SGA for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high TTM SGA is -$37.32M
What is Amicus Therapeutics, Inc. TTM SGA year-on-year change?
Over the past year, FOLD TTM SGA has changed by -$11.34B (-3812.08%)